dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade de São Paulo (USP)
dc.contributorFaculdade de Medicina de São José do Rio Preto (FAMERP)
dc.contributorHospital Israelita Albert Einstein
dc.date.accessioned2014-05-27T11:22:04Z
dc.date.available2014-05-27T11:22:04Z
dc.date.created2014-05-27T11:22:04Z
dc.date.issued2006-12-01
dc.identifierBrazilian Journal of Medical and Biological Research, v. 39, n. 12, p. 1575-1580, 2006.
dc.identifier0100-879X
dc.identifier1678-4510
dc.identifierhttp://hdl.handle.net/11449/69283
dc.identifier10.1590/S0100-879X2006001200008
dc.identifierS0100-879X2006001200008
dc.identifierWOS:000243103300008
dc.identifier2-s2.0-33847656226
dc.identifier2-s2.0-33847656226.pdf
dc.identifier7991082362671212
dc.identifier3279428066176719
dc.identifier0000-0001-5693-6148
dc.identifier0000-0002-4603-9467
dc.description.abstractHereditary hemochromatosis is a disorder of iron metabolism characterized by increased iron intake and progressive storage and is related to mutations in the HFE gene. Interactions between thalassemia and hemochromatosis may further increase iron overload. The ethnic background of the Brazilian population is heterogeneous and studies analyzing the simultaneous presence of HFE and thalassemia-related mutations have not been carried out. The aim of this study was to evaluate the prevalence of the H63D, S65C and C282Y mutations in the HFE gene among 102 individuals with alpha-thalassemia and 168 beta-thalassemia heterozygotes and to compare them with 173 control individuals without hemoglobinopathies. The allelic frequencies found in these three groups were 0.98, 2.38, and 0.29% for the C282Y mutation, 13.72, 13.70, and 9.54% for the H63D mutation, and 0, 0.60, and 0.87% for the S65C mutation, respectively. The chi-square test for multiple independent individuals indicated a significant difference among groups for the C282Y mutation, which was shown to be significant between the beta-thalassemia heterozygote and the control group by the Fisher exact test (P value = 0.009). The higher frequency of inheritance of the C282Y mutation in the HFE gene among beta-thalassemic patients may contribute to worsen the clinical picture of these individuals. In view of the characteristics of the Brazilian population, the present results emphasize the need to screen for HFE mutations in beta-thalassemia carriers.
dc.languageeng
dc.relationBrazilian Journal of Medical and Biological Research
dc.relation1.492
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectC282Y
dc.subjectH63D
dc.subjectHFE
dc.subjectS65C
dc.subjectThalassemia
dc.subjectHFE protein
dc.subjectalpha thalassemia
dc.subjectbeta thalassemia
dc.subjectBrazil
dc.subjectchi square test
dc.subjectclinical feature
dc.subjectcontrolled study
dc.subjectfemale
dc.subjectFisher exact test
dc.subjectgene frequency
dc.subjectgene mutation
dc.subjecthemoglobinopathy
dc.subjectheterozygote
dc.subjecthuman
dc.subjectinheritance
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectprevalence
dc.subjectthalassemia
dc.subjectalpha-Thalassemia
dc.subjectbeta-Thalassemia
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectGene Frequency
dc.subjectGenotype
dc.subjectHeterozygote
dc.subjectHistocompatibility Antigens Class I
dc.subjectHumans
dc.subjectMale
dc.subjectMembrane Proteins
dc.subjectMutation
dc.subjectPolymerase Chain Reaction
dc.titleHFE gene mutations in Brazilian thalassemic patients
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución